Earth Life Sciences Inc.
CLTS · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $19 | $16 | $30 | $11 |
| SG&A Expenses | $19 | $317 | $31 | $13 |
| Sales & Mktg Exp. | $0 | $301 | $0 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $317 | $31 | $13 |
| Operating Income | -$19 | -$317 | -$31 | -$13 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$5 | -$5 | -$5 |
| Pre-Tax Income | -$21 | -$322 | -$36 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21 | -$322 | -$36 | -$18 |
| % Margin | – | – | – | – |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | 92.8% | -705% | 0.3% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 970,681 | 976,457 | 960,469 | 494,645 |
| Weighted Avg Shares Out Dil | 970,681 | 976,457 | 960,469 | 494,645 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $5 | $0 | $5 |
| Depreciation & Amortization | $19 | $317 | $31 | $13 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |